The global chemo graded nitrile powder-free medical examination gloves market size is anticipated to reach USD 494.9 million by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 8.0% from 2019 to 2028. The increasing prevalence of cancer cases across the globe is likely to boost market growth over the forecast period.
A surge in the pervasiveness of cancer is majorly attributed to various risk factors such as smoking, alcohol use, lack of exercise, poor nutrition, and obesity. According to the International Agency for Research on Cancer, the total number of estimated cancer cases was 19.3 million in 2020, with around 10 million deaths.
As the number of cancer patients is increasing each year, there has been a strong emphasis on the early diagnosis of cancer. Early detection and screening have resulted in increased demand for chemotherapy. This, in turn, is anticipated to augment market growth over the forecast period.
Free Sample Report: www.grandviewresearch.com/industry-analysis/chemo-graded-nitrile-powder-free-medical-examination-gloves-market-report
The demand for chemo graded gloves is rising rapidly as the number of cancer patients is rising across the globe. Manufacturers are focused on launching new high-quality gloves. For instance, in March 2021, V12 Health launched a new product line of chemo graded nitrile powder-free medical examination gloves and TPET gloves.
Chemo Graded Nitrile Powder-free Medical Examination Gloves Market Report Highlights
- Asia Pacific accounted for revenue share of 42.1% in 2020 owing to the high cancer prevalence and high mortality rate caused by cancer in the region
- China is anticipated to witness a CAGR 8.7% over the forecast period, as the healthcare infrastructure is expanding rapidly, resulting in improving the cancer screening process and cancer treatment in China
- Germany is expected to witness a CAGR 7.5% over the forecast period on account of the presence of advanced infrastructure & technology coupled with government support to revolutionize medical treatment
- Manufacturers of chemo graded nitrile gloves are focusing on rising production capacity by expanding their facilities. For instance, in March 2020, Hartalega purchased land to expand its glove production facilities in Malaysia
- Furthermore, the market players are focusing expansion of business footprints globally. For instance, in December 2020, Ansell Ltd. acquired the Primus brand to increase its presence in India
Key Companies & Market Share Insights
The manufacturers of chemo graded nitrile powder-free medical examination gloves are focusing on constructing new manufacturing facilities in various counties and expanding their existing facilities to increase the production capacity of gloves. For instance, in April 2019, Top Glove Corporation Bhd started the construction of several new factories, including 3 in Malaysia and 1 each in Thailand and Vietnam, which were completed by December 2020.
The key players are focused on research and development activities to develop improved technologies for the manufacturing of chemo graded nitrile powder-free medical examination gloves and integration across various stages of the value chain to gain a competitive edge in the market. Some of the prominent players in the global chemo graded nitrile powder-free medical examination gloves market include: Cardinal Health, Top Glove Corporation Bhd, Ansell Ltd., Kimberly-Clark Corporation, Sempermed USA, Halyard Health, Tronex International, McKesson Medical-Surgical Inc., Hartalega Holdings Berhad, Safeko
Buy Full Report: https://www.grandviewresearch.com/industry-analysis/chemo-graded-nitrile-powder-free-medical-examination-gloves-market-report